On September 10, 2018, the Court of Appeals for the Federal Circuit decided Regents of the Univ. of Calif. v. Broad Inst., Inc.,[1] in the latest court battle in the CRISPR patent challenge pitting three of the nation’s largest research universities against each other. CRISPR, or “Clustered Regularly Interspaced Short Palindromic Repeats,” is a family …
